Public Health Response Measures for COVID-19 in Kazakhstan

被引:1
作者
Battakova, Zhamilya [1 ]
Imasheva, Bagdat [2 ]
Slazhneva, Tatyana [1 ]
Imashev, Marat [2 ]
Beloussov, Vyacheslav [3 ]
Pignatelli, Massimo [4 ]
Tursynkhan, Aigerim [4 ]
Askarov, Albert [1 ]
Abdrakhmanova, Shynar [1 ]
Adayeva, Assel [1 ]
Akimbayeva, Anara [1 ]
Suleimanova, Natalya [1 ]
机构
[1] Minist Hlth Republ Kazakhstan, Natl Ctr Publ Hlth, Astana, Kazakhstan
[2] Astana Med Univ, Astana, Kazakhstan
[3] LLP TreeGene, Alma Ata, Kazakhstan
[4] Nazarbayev Univ, Astana, Kazakhstan
关键词
COVID-19; Kazakhstan; control measures; cases; government response;
D O I
10.1017/dmp.2023.181
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The article describes measures developed to counter the spread of coronavirus infection in the Republic of Kazakhstan. The first cases of coronavirus disease 2019 (COVID-19) in Kazakhstan were detected on March 13, 2020, among people who arrived from Germany. After declaring the state of emergency in the country, the Ministry of Healthcare of the Republic of Kazakhstan began to formulate and implement a comprehensive package of measures aimed at slowing down and stopping the transmission of infection, preventing outbreaks, ensuring optimal care for all patients, especially the seriously ill, minimizing the negative impact of the pandemic on health systems, social services, and economic activities. Developed set of restrictive measures was approved by the Country Office of Word Health Organization (WHO) in Kazakhstan, being later adapted by the European Union (EU) countries and applied in Kyrgyzstan. In addition, article identifies Kazakhstan's experience in creating epidemiological surveillance systems, studying virus mutations, and the clinical aspects of dealing with it to combat the infection. It also indicates the impact of the epidemic on health-care workers and the development of measures to protect them, strengthening infection prevention, and control in medical organizations.
引用
收藏
页数:5
相关论文
共 33 条
[1]   New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications [J].
Abdool Karim, Salim S. ;
de Oliveira, Tulio .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (19) :1866-1868
[2]  
[Anonymous], 2020, REPORT 2 ESTIMATING
[3]  
[Anonymous], 2021, Newspaper "KursivMarch 12
[4]   Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis [J].
Chmielewska, Barbara ;
Barratt, Imogen ;
Townsend, Rosemary ;
Kalafat, Erkan ;
van der Meulen, Jan ;
Gurol-Urganci, Ipek ;
Brien, Pat O. ;
Morris, Edward ;
Draycott, Tim ;
Thangaratinam, Shakila ;
Le Doare, Kirsty ;
Ladhani, Shamez ;
von Dadelszen, Peter ;
Magee, Laura ;
Khalil, Asma .
LANCET GLOBAL HEALTH, 2021, 9 (06) :E759-E772
[5]  
Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan, List of vaccines against coronavirus infection COVID-19 registered in the Republic of Kazakhstan
[6]  
Corman Victor M., 2020, 2019 NOV COR 2019 NC, V25
[7]   Multisystem Inflammatory Syndrome in US Children and Adolescents [J].
Feldstein, Leora R. ;
Rose, Erica B. ;
Horwitz, Steven M. ;
Collins, Jennifer P. ;
Newhams, Margaret M. ;
Son, Mary Beth F. ;
Newburger, Jane W. ;
Kleinman, Lawrence C. ;
Heidemann, Sabrina M. ;
Martin, Amarilis A. ;
Singh, Aalok R. ;
Li, Simon ;
Tarquinio, Keiko M. ;
Jaggi, Preeti ;
Oster, Matthew E. ;
Zackai, Sheemon P. ;
Gillen, Jennifer ;
Ratner, Adam J. ;
Walsh, Rowan F. ;
Fitzgerald, Julie C. ;
Keenaghan, Michael A. ;
Alharash, Hussam ;
Doymaz, Sule ;
Clouser, Katharine N. ;
Giuliano, John S. ;
Gupta, Anjali ;
Parker, Robert M. ;
Maddux, Aline B. ;
Havalad, Vinod ;
Ramsingh, Stacy ;
Bukulmez, Hulya ;
Bradford, Tamara T. ;
Smith, Lincoln S. ;
Tenforde, Mark W. ;
Carroll, Christopher L. ;
Riggs, Becky J. ;
Gertz, Shira J. ;
Daube, Ariel ;
Lansell, Amanda ;
Coronado Munoz, Alvaro ;
Hobbs, Charlotte V. ;
Marohn, Kimberly L. ;
Halasa, Natasha B. ;
Patel, Manish M. ;
Randolph, Adrienne G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (04) :334-346
[8]  
2021, medRxiv, DOI [10.1101/2021.03.10.21252820, 10.1101/2021.03.10.21252820, DOI 10.1101/2021.03.10.21252820]
[9]   Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study [J].
Gaudart, Jean ;
Landier, Jordi ;
Huiart, Laetitia ;
Legendre, Eva ;
Lehot, Laurent ;
Bendiane, Marc Karim ;
Chiche, Laurent ;
Petitjean, Aliette ;
Mosnier, Emilie ;
Kirakoya-Samadoulougou, Fati ;
Demongeot, Jacques ;
Piarroux, Renaud ;
Rebaudet, Stanislas .
LANCET PUBLIC HEALTH, 2021, 6 (04) :E222-E231
[10]  
[Горенков Д.В. Gorenkov D.V.], 2020, [Биопрепараты. Профилактика, диагностика, лечение, BIOpreparations. Prevention, Diagnosis, Treatment, Biopreparaty. Profilaktika, diagnostika, lechenie], V20, P6, DOI 10.30895/2221-996X-2020-20-1-6-20